Literature DB >> 7876880

A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy.

K Iwahashi, R Miyatake, Y Tsuneoka, Y Matsuo, Y Ichikawa, K Hosokawa, K Sato, T Hayabara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7876880      PMCID： PMC1073346          DOI： 10.1136/jnnp.58.2.263

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.

Authors:  C A Smith; A C Gough; P N Leigh; B A Summers; A E Harding; D M Maraganore; S G Sturman; A H Schapira; A C Williams; D M Maranganore
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

Review 2.  Multiple system atrophy--the nature of the beast.

Authors:  N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine.

Authors:  A Barbeau; T Cloutier; M Roy; L Plasse; S Paris; J Poirier
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

4.  Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes.

Authors:  M Yoshida; T Niwa; T Nagatsu
Journal:  Neurosci Lett       Date:  1990-10-30       Impact factor: 3.046

5.  Mutant debrisoquine hydroxylation genes in Parkinson's disease.

Authors:  M Armstrong; A K Daly; S Cholerton; D N Bateman; J R Idle
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

6.  Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.

Authors:  S Ohta; O Tachikawa; Y Makino; Y Tasaki; M Hirobe
Journal:  Life Sci       Date:  1990       Impact factor: 5.037
  6 in total
  6 in total

Review 1.  Epidemiological evidence on multiple system atrophy.

Authors:  N Vanacore
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

Review 2.  Multiple system atrophy: cellular and molecular pathology.

Authors:  D J Burn; E Jaros
Journal:  Mol Pathol       Date:  2001-12

3.  Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy.

Authors:  Sarah J Lincoln; Owen A Ross; Nicole M Milkovic; Dennis W Dickson; Alex Rajput; Christopher A Robinson; Spiridon Papapetropoulos; Deborah C Mash; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2007-02-08       Impact factor: 4.891

4.  Genetic players in multiple system atrophy: unfolding the nature of the beast.

Authors:  Sylvia Stemberger; Sonja W Scholz; Andrew B Singleton; Gregor K Wenning
Journal:  Neurobiol Aging       Date:  2011-05-24       Impact factor: 4.673

5.  Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy.

Authors:  O Bandmann; G K Wenning; N P Quinn; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

Review 6.  Multiple system atrophy: genetic or epigenetic?

Authors:  Edith Sturm; Nadia Stefanova
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.